Language selection

Search

2010-05-07 - Female - 32 Years old

343124

Adverse reaction report number 343124
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2010-05-07
Latest received date 2010-05-07
Age 32 Years
Gender Female
Weight 160 Pounds
Type of report Spontaneous
Reporter type Pharmacist
Source of report Community
Report outcome Recovered/resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 30MGSuspectOral30 Milligram1 every 1 Day(s)32 Day(s)Attention deficit/hyperactivity disorder
ADDERALL XR 30MGCAPSULE, EXTENDED RELEASESuspectOral30 Milligram1 every 1 Day(s)30 Day(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Pruritus
Rash erythematous
Urticaria
Date modified: